Image
Back to top
Prof Diamant Thaçi
Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine
Professor Diamant Thaçi is Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine, University of Lübeck, Germany. Professor Thaçi is also Chairman of the Inflammatory Board at the University Hospital Schleswig-Holstein, Lübeck Campus.
He is an active member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council (IPC), the International Eczema Council (IEC), and the Skin Inflammation & Psoriasis International Network (SPIN). His research interests cover immunological work in basic research and all stages of clinical drug development, with a focus on chronic inflammatory skin diseases.
0 resources
Image
Video4:25 min
Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy
EU-BK-2400332
Image
Video5:28 min
Informed decisions for effective HS management
Different HS phenotypes and disease severity scores: their role in informing management decisions
EU-DC-2400079
Image
Video6:27 min
The role of surgery in HS management: Optimising patient results
Surgical management of HS, through minor procedures to more complex interventions
EU-DA-2400505
Image
Video6:08 min
Recognising HS symptoms: Diagnosis and what you need to know
Key criteria for diagnosing HS, common misdiagnoses and how AI can be used to assess disease severity
EU-DA-2400504
Image
Video7:01 min
Taking a holistic approach: HS and its comorbidities
HS often presents with comorbidities extending beyond the skin. A holistic approach is essential for effective HS management
EU-DA-2400503
Image
Video8:11 min
The invisible impact of HS: Hearing the patient experience
HS presents diverse challenges for patients, across many key aspects of life. Insights into these complex burdens provides the foundation for essential support
EU-DA-2400502